Showing 466 to 480 of 1932 results
Education data and reports
Insight into our work in approving and monitoring programmes offered by UK education providers
Guidance on the use of social media
How to ensure you meet our standards by using social media effectively and sensitively
Expectations of Education Providers
Our expectations related to safety and EDI. We provide examples of what the standards might look like in practice and signpost to external resources,
Engaging with the public about what they do via social media
Case study: Simon is a dietitian. He has recently been considering new ways of engaging with his service users and members of the public
Developing and sharing skills and knowledge and networking with other professionals using social media
Case study: Kathy is an occupational therapist, working in the NHS, and has recently trained as a best interests assessor
HCPC response to the DHSC consultation on mandatory vaccination for frontline health and care staff
View our response to the Department of Health and Social Care consultation on mandatory vaccination for frontline health and care staff.
Support for those who have experienced sexual misconduct
If you are not ready to speak to us, you could contact another organisationthat has specific expertise in supporting people who have experienced or are experiencing sexual harassment, violence or abuse.
Information for learners
This page outlines some considerations for learners who witness or experience discrimination in education settings.
COVID-19 our approach to temporary registration
We have worked with the UK Government to create a COVID-19 temporary register, of two parts
HCPC appoints new Council members, at critical moment for health and care professionals
The HCPC has today announced the appointment of two new lay Council members, John McEvoy and Lianne Patterson.
Joint statement on meeting regulatory standards during periods of global or national shortage of medicines
We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).